"On December 16, 2014, the U. S. Food and Drug Administration approved lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroe"...
Uvadex Consumer (continued)
Some products that may interact with this drug include: anthralin, bacteriostatic soaps, coal tar, certain dyes (methylene blue, toluidine blue, rose bengal, methyl orange), griseofulvin, nalidixic acid, phenothiazines (e.g., promethazine, thiothixene), sulfa antibiotics (e.g., sulfamethoxazole, sulfisoxazole), tetracycline antibiotics (e.g., doxycycline, tetracycline), certain "water pills" (thiazide diuretics such as hydrochlorothiazide).
OVERDOSE: If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center. Symptoms of overdose may include: serious burning/blistering of skin.
NOTES: Laboratory and/or medical tests (e.g., blood counts) should be performed periodically to monitor your progress or check for side effects. Consult your doctor for more details.
MISSED DOSE: For the best possible benefit, it is important to receive each scheduled treatment with this medication as directed. If you miss a treatment, contact your doctor to establish a new treatment schedule.
STORAGE: Not applicable. This medication is given in a hospital or clinic and will not be stored at home.
Information last revised December 2013. Copyright(c) 2013 First Databank, Inc.
Additional Uvadex Information
- Uvadex Drug Interactions Center: methoxsalen inj
- Uvadex Side Effects Center
- Uvadex Overview including Precautions
- Uvadex FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
Get the latest treatment options.